Tatva Chintan IPO Subscription Status: FINAL
Tatva Chintan Pharma Chem Limited, incorporated in 1996, is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for supercapacitor batteries, and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”).
Tatva Chintan IPO Subscription: End of Day Update
|Day||Day 1||Day 2||Day 3|
Tatva Chintan IPO Subscription: Analyst Recommendations
To be Updated…
Tatva Chintan IPO Subscription: Key IPO Details
|Issue Size||₹500 Cr|
|Face Value||₹1/- per Equity Share|
|IPO Price||₹1073 – ₹1083|
|Lot Size||13 shares|
|Lots||Min 1 – Max 13|
Tatva Chintan IPO : Financials
|Revenue from Ops||₹206.31 Cr||₹2,63.24 Cr||₹300.36 Cr|
|Profit before Excep*||₹26.64 Cr||₹47.60 Cr||₹60.70 Cr|
|Profit after Tax||₹20.54 Cr||₹37.79 Cr||₹52.26 Cr|
|As of March 2020||EPS (Avg)||P/E (Floor)||P/E (Cap)|
|Based on basic EPS||20.99||51.12||51.60|
Comparison with listed industry peers
|As of March 2020||P/E|
|Tatva Chintan Pharma||51.60|
Tatva Chintan IPO Subscription – FAQs
1. How to apply for Tatva Chintan IPO in the Retail Category?
A: An investor in the retail category may either apply through the UPI process via DEMAT account or the ASBA process via bank account
2. How to apply for Tatva Chintan in HNI Category?
A: An investor can apply in the HNI category only through the ASBA process via bank account
3. Where can I find the Red Herring Prospectus (RHP) details?
A: You can visit the NSE or SEBI website for these details. Alternately you can click here: RHP